351-33-7

Basic information

• Product Name: 2-CHLORO-N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE
• Synonyms: OTAVA-BB BB7010640154;2-CHLORO-N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE;AKOS USSH-4110460;AKOS BBS-00003883
• CAS NO: 351-33-7
• Molecular Formula: C₉H₆Cl₂F₃NO
• Molecular Weight: 272.05
• Mol File: 351-33-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-CHLORO-N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE(351-33-7)
• EPA Substance Registry System: 2-CHLORO-N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDE(351-33-7)

Safety Data

• Hazardous Substances Data: 351-33-7(Hazardous Substances Data)

Upstream product

• 79-04-9 chloroacetyl chloride 
• 320-51-4 4-chloro-3-trifluoromethyl-aniline 

Downstream Products

• 847606-77-3 N-[4-chloro-3-(trifluoromethyl)phenyl]-2-[(4-pyrimidin-5-ylphenyl)oxy]acetamide 
• 847608-10-0 tert-butyl 2-(4-(2-((4-chloro-3-(trifluoromethyl)phenyl)amino)-2-oxoethoxy)phenyl)-1H-indole-1-carboxylate 
• 847606-76-2 N-[4-chloro-3-(trifluoromethyl)phenyl]-2-{[3-(1H-tetrazol-1-yl)phenyl]thio}acetamide 
• 847606-73-9 N'-[4-chloro-3-(trifluoromethyl)phenyl]-N-[3-(1H-tetrazol-1-yl)phenyl]glycinamide 
• 847608-67-7 N-[4-chloro-3-(trifluoromethyl)phenyl]-2-{[4-(5-hydroxy-1H-tetrazol-1-yl)phenyl]oxy}acetamide 
• 352347-24-1 2-(4-bromo-phenoxy)-N-(4-chloro-3-trifluoromethyl-phenyl)acetamide 
• 875656-36-3 N-(4-chloro-3-trifluoromethylphenyl)-2-[(R)-1-(3,4-dimethoxyphenyl)-ethylamino]-acetamide 

Relevant articles and documents

N-Heterocyclic Carbene-Catalyzed Synthesis of 2-Aryl Indoles

Transition metal-free catalytic methods for access to 2-arylindole compounds.

Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics

Small molecule choline kinase inhibitors having the following formula: are provided herein. Also provided herein are pharmaceutical compositions containing Formula I compounds, together with methods of treating cancer, methods of inhibiting choline kinase enzymatic activity, and methods of treating tumors by administering an effective amount of a Formula I compound.

C-KIT MODULATORS AND METHODS OF USE

The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Even more specifically, the invention